COVID-19

As UW Health and the University of Wisconsin begin scheduling participants for the AstraZeneca COVID-19 vaccine study, experts and leaders are focused on equity and inclusion to ensure a diverse population takes part in this phase 3 clinical trial. A diverse group of participants will give researchers the best understanding on how and if this vaccine works for everyone....

A COVID-19 vaccine clinical trial is now underway at UW Health. The Clinical Research Unit at University hospital is vaccinating the first participants in the AstraZeneca COVID-19 clinical trial....

UW Health and the University of Wisconsin will become one of the first sites in the country to study whether a new vaccine can prevent COVID-19....

The following webinar, presented via a collaboration between the Foundation for Black Women's Wellness, the UW-Madison Collaborative Center for Health Equity, and the 'All of Us' Research Program at UW-Madison, highlights the importance of African American communities' participation in health research....

Even during the COVID-19 pandemic, mortality rates and life expectancy are far better for white Americans than they are for Black people during normal, non-pandemic years....

Our country needs a new path forward in the battle against COVID-19 Wisconsin's two medical schools are heading up this fight by launching innovative clinical trials, developing rapid diagnostic testing, studying the complexities of this virus and increasing our capacity to offer telehealth and virtual visits. Our health care professionals are working tirelessly. But these frontline fighters need support from everyone to limit the spread of this virus....

While the federal government has spent billions in an unprecedented effort to fast-track a vaccine that could be approved in just a few months, the rollout will be fraught with moral, ethical and political issues. Who gets it first? Who wants it? And who doesn’t? In this Q&A, UW-Madison's Dr. Jonathan Temte discusses these issues and more....

The Food and Drug Administration is nearing a decision to authorize emergency use of antibody-rich blood plasma from recovered Covid-19 patients for treating those infected with the coronavirus....

Our co-principal investigator, Dr. Elizabeth Burnside appeared on Wisconsin Public Radio's "Morning Show" to discuss the All of Us Research Program's efforts in Wisconsin, including the program's involvement in COVID-19 research....

Much of the study on the immune response to SARS-CoV-2, the novel coronavirus that causes COVID-19, has focused on the production of antibodies. But, in fact, immune cells known as memory T cells also play an important role in the ability of our immune systems to protect us against many viral infections, including—it now appears—COVID-19....